Conditions

South Korea, Aug. 14, 2026 /PRNewswire/ — SK bioscience announced that it has submitted a Clinical Trial Application (CTA) to the South African Health Products Regulatory Authority (SAHPRA) for a global pediatric Phase 1b clinical trial of RSM01, a respiratory syncytial virus (RSV) preventive antibody candidate licensed from the Gates Medical Research Institute (Gates MRI),…